Success Story
3.5% Boost in First-Fill Rate of Injectable Specialty Medication
See how personalized patient engagement boosts first-fill rates and delivers significant revenue growth.
Overcoming access barriers and improving adherence for injectable biologics can be challenging.
This success story reveals how a leading pharmaceutical brand achieved:
- A 3.5% absolute incremental NRx lift.
- $20M in gross incremental revenue.
- 75%+ engagement across 22,000 NRx targeted patients.
Learn how targeted SMS outreach can transform your specialty medication performance.
